By AWE Staff
AWE New York Leader, Melissa Trombetta, Head of Global Investor Relations at Mylan was featured last month in Nasdaq’s IRO campaign. In the interview she discusses her top priorities, challenges, useful resources, and advice that she’d give to the next generation of IRO leaders.
Currently, Melissa is Head of Global Investor Relations at Mylan N.V., a leading global pharmaceutical company whose differentiated business model focuses on access, durability, and diversification. With more than 10 years of investor relations experience, Melissa joined the company in 2017, and brings to her current role investor communication expertise, a deep knowledge of the investor community, and broad-based finance experience.
Mylan is a global pharmaceutical company committed to providing 7 billion people access to high quality medicine. They offer a growing portfolio of more than 7,500 marketed products in more than 165 countries and territories. They are one of the world’s largest producers of active pharmaceutical ingredients. Every member of their approximately 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time.